THE REPLICATION OF VIRAL AND CELLULAR DNA IN HUMAN HERPESVIRUS 6-INFECTED CELLS

被引:56
作者
DILUCA, D
KATSAFANAS, G
SCHIRMER, EC
BALACHANDRAN, N
FRENKEL, N
机构
[1] NIAID,VIRAL DIS LAB,NIH TWINBROOK 2,12441 PARKLAWN DR,ROCKVILLE,MD 20852
[2] UNIV PARIS 11,DEPT MICROBIOL,F-91405 ORSAY,FRANCE
关键词
D O I
10.1016/0042-6822(90)90200-B
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Human herpesvirus 6 (HHV-6) is a newly identified lymphotropic herpesvirus. We have analyzed viral and host DNA replication in peripheral blood lymphocytes infected in the absence of drugs or infected in the presence of phosphonoacetic acid (PAA) or acyclovir (ACV). The results revealed the following: (i) Infection with HHV-6 resulted in the shutoff of host DNA replication. (ii) PAA at concentrations of 100 and 300 μg/ml significantly reduced virus replication. The drug inhibited viral DNA replication, whereas host cell DNA replication was not affected. This strongly suggests that HHV-6 encodes a PAA sensitive viral DNA polymerase. (iii) ACV at 20 μM did not interfere with virus production and virus spread. ACV at 100 μM only partly interfered with virus replication, whereas at 400 μM the block was more complete. Viral DNA replication was not affected by ACV at 20 μM. However, approximately 60 and 85% inhibition in viral DNA replication was observed in the presence of 100 and 400 μM of ACV. (iv) Assays for viral thymidine kinase (TK) revealed no significant increase in TK activity, whereas increased TK activity was noted following infection of the same peripheral blood lymphocytes with herpes simplex virus. Thus, either HHV-6 does not encode a tk enzyme which can phosphorylate ACV or the inefficient block may reflect lower sensitivity of the HHV-6 DNA polymerase to the drug. © 1990.
引用
收藏
页码:199 / 210
页数:12
相关论文
共 28 条
[1]   HUMAN B-LYMPHOTROPIC VIRUS (HUMAN HERPESVIRUS-6) [J].
ABLASHI, DV ;
JOSEPHS, SF ;
BUCHBINDER, A ;
HELLMAN, K ;
NAKAMURA, S ;
LLANA, T ;
LUSSO, P ;
KAPLAN, M ;
DAHLBERG, J ;
MEMON, S ;
IMAM, F ;
ABLASHI, KL ;
MARKHAM, PD ;
KRAMARSKY, B ;
KRUEGER, GRF ;
BIBERFELD, P ;
WONGSTAAL, F ;
SALAHUDDIN, SZ ;
GALLO, RC .
JOURNAL OF VIROLOGICAL METHODS, 1988, 21 (1-4) :29-48
[2]  
AGUT H, 1988, LANCET, V1, P712
[3]   IDENTIFICATION OF PROTEINS SPECIFIC FOR HUMAN HERPESVIRUS-6-INFECTED HUMAN T-CELLS [J].
BALACHANDRAN, N ;
AMELSE, RE ;
ZHOU, WW ;
CHANG, CK .
JOURNAL OF VIROLOGY, 1989, 63 (06) :2835-2840
[4]   IDENTIFICATION AND SOME PROPERTIES OF A UNIQUE DNA-POLYMERASE FROM CELLS INFECTED WITH HUMAN B-LYMPHOTROPIC VIRUS [J].
BAPAT, AR ;
BODNER, AJ ;
TING, RCY ;
CHENG, YC .
JOURNAL OF VIROLOGY, 1989, 63 (03) :1400-1403
[5]  
BECKER WB, 1989, LANCET, V1, P41
[6]  
BRIDGEN D, 1981, ANTIVIR RES, V1, P203
[7]   ENHANCEMENT OF METHOTREXATE RESISTANCE AND DIHYDROFOLATE-REDUCTASE GENE AMPLIFICATION BY TREATMENT OF MOUSE 3T6-CELLS WITH HYDROXYUREA [J].
BROWN, PC ;
TLSTY, TD ;
SCHIMKE, RT .
MOLECULAR AND CELLULAR BIOLOGY, 1983, 3 (06) :1097-1107
[8]   HERPES-SIMPLEX VIRUS AMPLICON - CLEAVAGE OF CONCATEMERIC DNA IS LINKED TO PACKAGING AND INVOLVES AMPLIFICATION OF THE TERMINALLY REITERATED A-SEQUENCE [J].
DEISS, LP ;
FRENKEL, N .
JOURNAL OF VIROLOGY, 1986, 57 (03) :933-941
[9]   DRUGS 5 YEARS LATER - ACYCLOVIR [J].
DORSKY, DI ;
CRUMPACKER, CS .
ANNALS OF INTERNAL MEDICINE, 1987, 107 (06) :859-874
[10]  
FENWICK M, 1979, J VIROL, V29, P825, DOI 10.1128/JVI.29.2.825-827.1979